BACKGROUND Premenstrual disorders usually refer to Premenstrual Syndrome (PMS) and Premenstrual Dysphoric Disorder (PMDD). This study was designed to find out the frequency of premenstrual disorders and evaluate the associated factors in a sample of Iranian adolescents. OBJECTIVES This study was conducted to investigate the frequency of premenstrual disorders (PMS and PMDD) based on Premenstr...

INTRODUCTION Premenstrual syndrome is a common disorder in reproductive age and it is associated with decreased quality of life in women. In view of various factors contributing to outbreak of PMS (premenstrual syndrome) among women, the present study intended to compare lifestyles of university students with and without premenstrual syndromes living in dormitories of Qazvin University of Medic...

Objective: Premenstrual syndrome (PMS) occurs 7–14 days before the onset of menstruation and subsides with commencement menstrual flow, affects women during their reproductive age, is associated physical, psychological, behavioral changes. If mental symptoms predominate are very severe impairment, then patient classified as having premenstrual dysphoric disorder (PMDD) which may be viewed a sub...

AIM Consumption of soy isoflavones reduces the risk of estrogen-related diseases, such as menopausal symptoms, osteoporosis, and cardiovascular disease. Equol is metabolized from the isoflavone daidzein by intestinal bacteria and has higher bioavailability than other isoflavones. Equol producers are believed to benefit from soybean consumption to a greater extent than non-producers. Recently, w...

Part I Menstrual concerns are common problem in women’s health, encompassing a wide range of concerns including premenstrual syndrome (PMS), painful menstruation (dysmenorrhea), and irregular or absent periods (amenorrhea). These symptoms can be a part of several medical conditions including polycystic ovary syndrome (PCOS), endometriosis, and uterine fibroids. Although not life-threatening, th...

OBJECTIVE To systematically review evidence of the treatment benefits of selective serotonin reuptake inhibitors (SSRIs) for symptoms related to severe premenstrual syndrome (PMS) and premenstrual dysphoric disorder. DATA SOURCES We conducted electronic database searches of MEDLINE, Web of Science, Cochrane Library, Embase, PsycINFO, and Cinahl through March 2007, and hand-searched reference ...

BACKGROUND Studies show that selective serotonin reuptake inhibitors are effective for severe premenstrual syndrome and premenstrual dysphoric disorder. This study compares the efficacy of a selective serotonin reuptake inhibitor with that of a tricyclic antidepressant to determine whether efficacy for premenstrual syndrome/premenstrual dysphoric disorder is a general or more serotonergic effec...